Gene · 406940
Papers4,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients. | Bioengineering (Basel) | 2023 | 37892917 | PubTator, text mining | PubMed |
| Food-Derived Extracellular Vesicles as Multi-Bioactive Complex and Their Versatile Health Effects. | Antioxidants (Basel) | 2023 | 37891941 | PubTator, text mining | PubMed |
| Role of Non-Coding RNAs in TGF-β Signalling in Glioma. | Brain Sci | 2023 | 37891744 | PubTator, text mining | PubMed |
| Bovine oviductal organoids: a multi-omics approach to capture the cellular and extracellular molecular response of the oviduct to heat stress. | BMC Genomics | 2023 | 37891479 | PubTator, text mining | PubMed |
| MicroRNAs Signature Panel Identifies Heavy Drinkers with Alcohol-Associated Cirrhosis from Heavy Drinkers without Liver Injury. | Biology (Basel) | 2023 | 37887024 | PubTator, text mining | PubMed |
| Serum exosomal microRNA-1258 may as a novel biomarker for the diagnosis of acute exacerbations of chronic obstructive pulmonary disease. | Sci Rep | 2023 | 37884583 | PubTator, text mining | PubMed |
| Chonggu Granules Improve Cartilage Matrix Metabolism in Knee Osteoarthritis via the miR-148a-3p/Wnt/β-Catenin Pathway. | J Inflamm Res | 2023 | 37881649 | PubTator, text mining | PubMed |
| Rapid purification and multiparametric characterization of circulating small extracellular vesicles utilizing a label-free lab-on-a-chip device. | Sci Rep | 2023 | 37880299 | PubTator, text mining | PubMed |
| Innovative preconditioning strategies for improving the therapeutic efficacy of extracellular vesicles derived from mesenchymal stem cells in gastrointestinal diseases. | Inflammopharmacology | 2023 | 37874430 | PubTator, text mining | PubMed |
| MiR-21 Participates in Anti-VEGF-Induced Epithelial Mesenchymal Transformation in RPE Cells. | Clin Ophthalmol | 2023 | 37869043 | PubTator, text mining | PubMed |
| An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives. | Front Pharmacol | 2023 | 37860119 | PubTator, text mining | PubMed |
| Multiomic Approaches for Cancer Biomarker Discovery in Liquid Biopsies: Advances and Challenges. | Biomark Insights | 2023 | 37846373 | PubTator, text mining | PubMed |
| Clinical and biological significance of circulating miRNAs in chronic pancreatitis patients undergoing total pancreatectomy with islet autotransplantation. | Clin Transl Med | 2023 | 37846205 | PubTator, text mining | PubMed |
| Lipid metabolism as a target for cancer drug resistance: progress and prospects. | Front Pharmacol | 2023 | 37841917 | PubTator, text mining | PubMed |
| Exosomes as a delivery tool of exercise-induced beneficial factors for the prevention and treatment of cardiovascular disease: a systematic review and meta-analysis. | Front Physiol | 2023 | 37841310 | PubTator, text mining | PubMed |
| CircularRNA Hsa_circ_0093335 promotes hepatocellular carcinoma progression via sponging miR-338-5p. | J Cell Mol Med | 2023 | 37837352 | PubTator, text mining | PubMed |
| GPER: An Estrogen Receptor Key in Metastasis and Tumoral Microenvironments. | Int J Mol Sci | 2023 | 37834441 | PubTator, text mining | PubMed |
| Exosomal microRNA/miRNA Dysregulation in Respiratory Diseases: From Mycoplasma-Induced Respiratory Disease to COVID-19 and Beyond. | Cells | 2023 | 37830635 | PubTator, text mining | PubMed |
| CircUSP10 promotes liver cancer progression by regulating miR-211-5p/TCF12/EMT signaling pathway. | Heliyon | 2023 | 37829805 | PubTator, text mining | PubMed |
| Genomic communication via circulating extracellular vesicles and long-term health consequences of COVID-19. | J Transl Med | 2023 | 37817137 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406940/papers?page=11